The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective
Open accessAbstract
There is no evidence on benefits or harms of inhaled steroids in COVID-19. It is essential that epidemiological studies of COVID-19 include detailed information on comorbidities and prior medication to help answer this question.https://bit.ly/2XVwIsa
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
PAUWELS, R. A. (1996) · Arerugī/Arerugi · doi:10.15036/arerugi.45.792 · Cited by 9,994
Global Initiative for Chronic Obstructive Lung Disease (GOLD)
Rahman, M. M., & Siddiqui, M. M. R. (2017) · Anwer Khan Modern Medical College Journal · doi:10.3329/akmmcj.v7i1.31596 · Cited by 3,106
CDC Weekly, C., & The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) · China CDC Weekly · doi:10.46234/ccdcw2020.032 · Cited by 2,889
World Health Organization (2020) · Pediatria i Medycyna Rodzinna · doi:10.15557/pimr.2020.0003 · Cited by 1,329
The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) · PubMed Central · Cited by 1,278
SARS: systematic review of treatment effects
Stockman, L. J., Bellamy, R., & Garner, P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030343 · Cited by 1,217
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
Jeon, S., Ko, M., Lee, J., Choi, I., Byun, S. Y., Park, S., Shum, D., & Kim, S. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00819-20 · Cited by 675
Inhaled corticosteroids for stable chronic obstructive pulmonary disease
Yang, I. A., Clarke, M. S., Sim, E. H., & Fong, K. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002991.pub3 · Cited by 523
Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?
Halpin, D. M. G., Faner, R., Sibila, O., Badia, J. R., & Agusti, A. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30167-3 · Cited by 385
Self-citationMatsuyama, S., Kawase, M., Nao, N., Shirato, K., Ujike, M., Kamitani, W., Shimojima, M., & Fukushi, S. (2020) · Journal of Virology · doi:10.1128/jvi.01648-20 · Cited by 287
Yamaya, M., Nishimura, H., Deng, X., Sugawara, M., Watanabe, O., Nomura, K., Shimotai, Y., Momma, H., Ichinose, M., & Kawase, T. (2020) · Respiratory Investigation · doi:10.1016/j.resinv.2019.12.005 · Cited by 251
Singanayagam, A., Glanville, N., Girkin, J. L., Ching, Y. M., Marcellini, A., Porter, J. D., Toussaint, M., Walton, R. P., Finney, L. J., Aniscenko, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04574-1 · Cited by 196
The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15
Matsuyama, S., Kawase, M., Nao, N., Shirato, K., Ujike, M., Kamitani, W., Shimojima, M., & Fukushi, S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.11.987016 · Cited by 179
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD
Contoli, M., Pauletti, A., Rossi, M. R., Spanevello, A., Casolari, P., Marcellini, A., Forini, G., Gnesini, G., Marku, B., Barnes, N., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00451-2017 · Cited by 169
Inhaled Corticosteroids and the Risk of Pneumonia in People With Asthma
McKeever, T. M., Harrison, T., Hubbard, R., & Shaw, D. E. (2013) · CHEST Journal · doi:10.1378/chest.13-0871 · Cited by 149
Overview of Virus-induced Airway Disease
Johnston, S. L. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200502-018aw · Cited by 101
Budesonide and Formoterol Reduce Early Innate Anti-Viral Immune Responses In Vitro
Davies, J. M., Carroll, M. L., Li, H., Poh, A. M., Kirkegard, D., Towers, M. A., & Upham, J. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027898 · Cited by 92
Viral infections and asthma: an inflammatory interface?
Oliver, B. G. G., Robinson, P. D., Peters, M. J., & Black, J. (2014) · European Respiratory Journal · doi:10.1183/09031936.00047714 · Cited by 90
Diversity in the bronchial epithelial cell response to infection with different rhinovirus strains
Wark, P. A. B., Grissell, T. V., DAVIES, B., See, H. V., & Gibson, P. G. (2009) · Respirology · doi:10.1111/j.1440-1843.2009.01480.x · Cited by 89
Simpson, J. L., Carroll, M. L., Yang, I. A., Reynolds, P. N., Hodge, S. J., James, A. L., Gibson, P. G., & Upham, J. W. (2015) · CHEST Journal · doi:10.1016/j.chest.2015.12.018 · Cited by 86
Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responses
Bochkov, Y. A., Busse, W. W., Brockman‐Schneider, R. A., Evans, M. D., Jarjour, N. N., McCrae, C., Miller‐Larsson, A., & Gern, J. E. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-98 · Cited by 53
Nasal cytokine responses to natural colds in asthmatic children
Lewis, T. C., Henderson, T. A., Carpenter, A. R., Ramirez, I. A., McHenry, C. L., Goldsmith, A. M., Ren, X., Mentz, G. B., Mukherjee, B., Robins, T. G., et al. (2012) · Clinical & Experimental Allergy · doi:10.1111/cea.12005 · Cited by 50
Increased type 2 inflammation post rhinovirus infection in patients with moderate asthma
Southworth, T. W., Pattwell, C., Khan, N. U., Mowbray, S. F., Strieter, R. M., Erpenbeck, V. J., & Singh, D. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154857 · Cited by 32
Self-citationAissa, S., Knaz, A., Maatoug, J., Khedher, A., Benzarti, W., Abdelghani, A., Garrouche, A., Hayouni, A., Benzarti, M., Gargouri, I., et al. (2020) · BioMed Research International · doi:10.1155/2020/1031845 · Cited by 21
Cited by
Risk factors for severe and critically ill COVID‐19 patients: A review
Gao, Y., Ding, M., Dong, X., Zhang, J., Kursat Azkur, A., Azkur, D., Gan, H., Sun, Y., Fu, W., Li, W., et al. (2021) · Allergy · doi:10.1111/all.14657 · Cited by 1,402
Halpin, D. M. G., Criner, G. J., Papi, A., Singh, D., Anzueto, A., Martinez, F. J., Agusti, A. A., & Vogelmeier, C. F. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202009-3533so · Cited by 760
Self-citationRisk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality
Zhang, J.-J., Dong, X., Liu, G.-H., & Gao, Y.-D. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-022-08921-5 · Cited by 715
Edalatifard, M., Akhtari, M., Salehi, M., Naderi, Z., Jamshidi, A., Mostafaei, S., Najafizadeh, S. R., Farhadi, E., Jalili, N., Esfahani, M., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.02808-2020 · Cited by 410
Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19
Chhiba, K. D., Patel, G. B., Vu, T. H. T., Chen, M. M., Guo, A., Kudlaty, E., Mai, Q., Yeh, C., Muhammad, L. N., Harris, K. E., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.06.010 · Cited by 308
Metadata
- Authors
- Halpin, D. M. G., Singh, D., & Hadfield, R. M.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2020-04-27
- Volume
- 55
- Issue
- 5
- Pages
- 2001009
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W3017994966
- Cited by
- 310
- References
- 31
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.